WHAT
Researchers and clinicians worldwide working in migraine, headache and brain injury will share the field’s latest scientific advances at American Headache Society’s annual scientific meeting in Washington, DC.
BACKGROUND
Migraine, headache and related disorders are among the least understood and treated, despite the fact that they are among the world’s leading causes of disability and suffering. In the United States alone, it is estimated that more than 36 million men, women and children suffer with migraine, accounting for almost half of all years of life lost to disability attributed to neurological disorders. The Federal commitment to migraine research is about $20 million -- less than 55 cents per person – for a disease that costs the nation more than $29 billion a year in direct and indirect medical costs.
HIGHLIGHTS -- CONGRESS PAPERS / PRESENTATIONS
- Three New Studies on Promising CGRP-Targeting Medications in the Pipeline
- Use of Opioids to Treat Children with Migraine
- Impact of TBI on Employment and Marriage in Returning Mideast War Vets
- Migraine and Concussion in Young Athletes
- Telemedicine in Migraine Management
- MRI to Identify and Classify Migraine
- Migraine Prevalence in Teen Football Players
- Use of Evidence-Based Care for Children and Teens with Migraine
- Adequacy of Patient-Physician Communication in Diagnosis of Chronic Migraine
- When Migraine Patients are Most Likely to Take Triptans
- Are Migraine Patients Prescribed Too Many Opioids and Barbiturates?
To view the entire AHS meeting schedule, please click here: http://www.americanheadachesociety.org/57th_annual_scientific_meeting/schedule/
WHEN AND WHERE
Thursday, June 18 – Sunday, June 21, 2015Grand Hyatt Washington, 1000 H Street, NW, Washington, DC 20001
All study authors are available for one-on-one interviews prior to and during the meeting. All studies are embargoed until June 17. Please contact either Dennis Tartaglia at [email protected] (732) 545-1848 or Joyce Yaeger at [email protected] (917) 783-6105.
RSS